Ryan Pearson’s team will explore how engineered nanoparticles can safely retrain the immune system to reduce allergic airway inflammation.

Computer modeling finds the most promising compounds and guides their transformation into drugs.

Study will explore how an antibiotic-resistant bacterium survives in the body and how that knowledge could lead to new, more effective treatments.

Researchers aim to improve chemotherapy by enhancing drug efficacy and reducing heart toxicity through dual activation of CAR and Nrf2 pathways.

Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, of the School of Pharmacy is working to ensure drug delivery through the skin is safe and effective and just the right dose.

Paul Shapiro, PhD, and Jeffrey Hasday, MD, are developing a class of drugs that may be able to reset the natural balance of inflammation and prevent a number of serious diseases.

The Mass Spectrometry Center at UMSOP is a collaborative hub where cutting-edge instrumentation and scientific expertise come together to solve complex research challenges and support groundbreaking discoveries across the globe.

Researchers are developing a novel therapy using safe, drug-free nanoparticles to aid the body in fighting sepsis more effectively.

Allan Doctor, MD, of the School of Medicine and Joga Gobburu, PhD, MBA, of the School of Pharmacy are optimistic they are on the cusp of developing the world’s first viable artificial blood.

Ceremonies honor six academic programs and the next generation of health care leaders, researchers, and advocates .

Exciting exhibition reaffirms the School’s commitment to scholarly inquiry across disciplines.

Leadership role provides oversight for grant and contract submissions and identification of funding sources and initiates collaborative and translational research programs.